BIOMAT Database Logo BIOMAT Database Logo

[Comparative study of antineoplastic and immunosuppressive properties of ftorafur]. 1976

T A Nosova, and V A Babichev, and B S Uteshev

In experiments staged on mice with transplantable leukemia L 1210 an immunodepressive and antineoplasic action of phthorafur was studied. Depending upon its dose phthorafur lowered the number of lymphoma colonies and antibody-forming cells in the spleen of the animals immunized with sheep erythrocytes. The maximal immunodepressive action was found to set in following administration of the agent in a dose of 500 mg/kg 24 and 48 hours after antigenic stimulation.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207

Related Publications

T A Nosova, and V A Babichev, and B S Uteshev
[Change of toxic and antineoplastic properties of ftorafur by means of action on nonspecific microsomal oxidase].
October 1979, Biulleten' eksperimental'noi biologii i meditsiny,
T A Nosova, and V A Babichev, and B S Uteshev
[Mechanism of action of ftorafur, a new antineoplastic agent].
January 1972, Voprosy meditsinskoi khimii,
T A Nosova, and V A Babichev, and B S Uteshev
Comparative studies on the immunosuppressive effect among 5'-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil.
April 1980, Gan,
T A Nosova, and V A Babichev, and B S Uteshev
Some antineoplastic and immunosuppressive agents.
May 1981, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
T A Nosova, and V A Babichev, and B S Uteshev
Nephrotoxicities of antineoplastic and immunosuppressive agents.
October 1984, Current problems in cancer,
T A Nosova, and V A Babichev, and B S Uteshev
[Carcinogenic effects of antineoplastic and immunosuppressive agents].
September 1971, Arzneimittel-Forschung,
T A Nosova, and V A Babichev, and B S Uteshev
[Comparative evaluation of the antineoplastic properties of antibiotic 6270 and echinomycin].
April 1962, Antibiotiki,
T A Nosova, and V A Babichev, and B S Uteshev
Guidelines for handling antineoplastic and immunosuppressive drugs.
December 1997, Australian veterinary journal,
T A Nosova, and V A Babichev, and B S Uteshev
Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
January 1972, Drugs,
T A Nosova, and V A Babichev, and B S Uteshev
[Pharmacological compatibility of the antineoplastic drugs ftorafur and 5-fluorouracil with the psychotropic drugs aminazine and phenazepam (an experimental study)].
January 1984, Vestnik Akademii meditsinskikh nauk SSSR,
Copied contents to your clipboard!